Accelerate Diagnostics, Inc (31)

Browse by Contract Category

Contracts

Separation Agreement and Release, dated December 8, 2022, by and between the Company and Ron Price (Filed With SEC on December 13, 2022)
Sales and Marketing Agreement, dated as of August 15, 2022, by and between the Registrant and Becton, Dickinson and Company (Filed With SEC on November 14, 2022)
Underwriting Agreement, dated August 18, 2022, by and between Accelerate Diagnostics, Inc. and William Blair & Company, L.L.C., as representative of the several underwriters named... (Filed With SEC on August 23, 2022)
Agreement between Registrant and Jack Phillips, dated as of January 31, 2020 (Filed With SEC on February 28, 2020)
Security Agreement, dated as of August 15, 2022, by and between the Company and the Jack W. Schuler Living Trust (Filed With SEC on August 15, 2022)
Warrant, dated as of August 15, 2022, issued to the Jack W. Schuler Living Trust (Filed With SEC on August 15, 2022)
Secured Promissory Note, dated as of August 15, 2022, by the Company in favor of the Jack W. Schuler Living Trust (Filed With SEC on August 15, 2022)
Exchange Agreement, dated as of August 15, 2022, by and between the Company and the Jack W. Schuler Living Trust (Filed With SEC on August 15, 2022)
Accelerate Diagnostics, Inc. 2022 Omnibus Equity Incentive Plan (Filed With SEC on May 17, 2022)
Securities Purchase Agreement, dated March 24, 2022, by and between Accelerate Diagnostics, Inc. and the Jack W. Schuler Living Trust (Filed With SEC on March 25, 2022)
Description of our Capital Stock Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 14, 2022)
Form of Exchange Agreement (Filed With SEC on September 23, 2021)
Securities Purchase Agreement, dated September 22, 2021, by and among Accelerate Diagnostics, Inc., the Tanya Eva Schuler Trust, the Therese Heidi Schuler Trust and Schuler... (Filed With SEC on September 23, 2021)
Rescission Agreement, dated September 17, 2021, by and among Accelerate Diagnostics, Inc., the Tanya Eva Schuler Trust, the Therese Heidi Schuler Trust, Schuler Grandchildren LLC... (Filed With SEC on September 23, 2021)
Sales Agreement, dated as of May 28, 2021, by and among Accelerate Diagnostics, Inc. and William Blair & Company, L.L.C (Filed With SEC on May 28, 2021)
Registration Rights Agreement, dated December 24, 2020, by and among Accelerate Diagnostics, Inc. and the purchasers party thereto (Filed With SEC on December 28, 2020)
Securities Purchase Agreement, dated December 24, 2020, by and among Accelerate Diagnostics, Inc. and the purchasers party thereto (Filed With SEC on December 28, 2020)
Addendum A to Promissory Note, dated April 14, 2020, by and between Registrant and Zions (Filed With SEC on November 6, 2020)
Consulting Services Agreement by and between Registrant and Romney Humphries, dated May 5, 2020 (Filed With SEC on August 10, 2020)
Sixth Amendment to the Accelerate Diagnostics, Inc. 2012 Omnibus Equity Incentive Plan (Filed With SEC on May 14, 2020)
Promissory Note, dated April 14, 2020, by and between Accelerate Diagnostics, Inc. and Zions Bancorporation, N.A. dba National Bank of Arizona (Filed With SEC on April 20, 2020)
Form of 2020 Salary Waiver Agreement (Filed With SEC on April 8, 2020)
2020 Salary Waiver and Nonqualified Stock Option Grant Plan (Filed With SEC on April 8, 2020)
Transition Agreement, Part-Time Employment Agreement, and General Release of Claims between Lawrence Mehren and the Registrant, dated December 1, 2019 (Filed With SEC on February 28, 2020)
Description of our Capital Stock Registered Pursuant to Section 12 of the Securties Exchange Act of 1934 (Filed With SEC on February 28, 2020)
Securities Purchase Agreement, dated August 20, 2019, between Accelerate Diagnostics, Inc. and John J. Phillips Investment Irrevocable Trust, dated July 31, 2019 (Filed With SEC on August 21, 2019)
Nonqualified Stock Option Agreement between Accelerate Diagnostics, Inc. and John J. Phillips, dated August 6, 2019 (Filed With SEC on August 8, 2019)
Offer Letter between Accelerate Diagnostics, Inc. and John J. Phillips, dated August 6, 2019 (Filed With SEC on August 8, 2019)
Fifth Amendment to the Accelerate Diagnostics, Inc. 2012 Omnibus Equity Incentive Plan (Filed With SEC on May 15, 2019)
Separation Agreement and General Release, dated November 25, 2018, between Juan Manuel Martn Duaiges and the Registrant (Filed With SEC on March 1, 2019)
Specimen Common Stock Certificate (Filed With SEC on March 1, 2019)